Description
KB-0742 is a selective CDK9 inhibitor with potent anti-tumor activity in castration-resistant prostate cancer models.
Product Unit Size | Cost | Quantity | Stock |
---|
KB-0742 is a selective CDK9 inhibitor with potent anti-tumor activity in castration-resistant prostate cancer models.
Cas No. | 2170137-61-6 (free base) |
---|---|
Purity | ≥98% |
Formula | C16H25N5 |
Formula Wt. | 287.41 |
IUPAC Name | (1S,3S)-3-N-(5-pentan-3-ylpyrazolo[1,5-a]pyrimidin-7-yl)cyclopentane-1,3-diamine |
Synonym | KB0742, NSC-834161, NSC834161 |
Appearance | Yellow to brown crystal |
Store Temp | -20°C |
---|---|
Ship Temp | Ambient |
Info Sheet |
---|
Richters A, Doyle S, Freeman D, et al. Modulating androgen receptor-driven transcription in prostate cancer with selective CDK9 inhibitors. Cell Chem Biol. 2021 Feb 18;28(2):134-147. PMID: 33086052
PI3K and mTOR inhibitor.
NDRI inhibitor
Water-soluble cortisol derivative; glucocortico...
Triterpene saponin found in species of Panax.
Purine (hypoxanthine) analog; xanthine oxidase ...
Fat-soluble vitamin C derivative.
Arginine source used to increase NO production....
Microtubule depolymerization inhibitor.
PRMT5 inhibitor
NSAID; COX-1/2 inhibitor.
Taxane synthesis intermediate.
Peptide; α4β1 integrin activator.
p110α and p110γ PI3K inhibitor.
Nucleoside (adenosine) analog; DNA chain termin...
AhR agonist.
CD73 inhibitor
Polymer precursor
Shellfish toxin produced by dinoflagellates and...
Vitamin D2, ergocalciferol metabolite; VDR agon...
Valsartan impurity